XENE profile · all as-reported value updates
Xenon Pharmaceuticals Inc. (XENE) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2023 | -145,327,000 | -151,112,000 | -5,785,000 | -3.83% | revised comparative figure | 0000950170-24-023177 0001193125-26-076650 | 3 filed observations examined for this concept and period. |
| Operating cash flow | 2022 | -98,430,000 | -101,028,000 | -2,598,000 | -2.57% | revised comparative figure | 0000950170-23-005582 0000950170-25-029149 | 3 filed observations examined for this concept and period. |